Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine.
about
Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infectionPhage display--a powerful technique for immunotherapy: 2. Vaccine deliveryPhage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model.Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.Phage display creates innovative applications to combat hepatitis B virusMimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivoArchitectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesTargeting glioblastoma via intranasal administration of Ff bacteriophages.Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: an in vivo study.Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.Advances in the study of nodavirus.Phage displayed HBV core antigen with immunogenic activityEvolution of phage display: from bioactive peptides to bioselective nanomaterials
P2860
Q26795483-5D6E602E-DD97-41E3-BD6C-59254440A5DAQ26822719-2BCF528E-E17B-4EB1-9E9B-759847F1B11EQ26865013-8C50068B-7BBA-4371-8F88-7005E51799AEQ31045955-FDB5A5D8-ED3F-42BB-9F97-1DA5DB4912EDQ33695321-2B931C62-50F8-49F6-B5FE-25342B5259D7Q34137308-8F2D280E-090E-4AA5-8D55-51394331FFA9Q34344080-6A59E3A1-A973-4DFA-A049-3DCCCD79BE3DQ34348477-B86064A2-0108-457E-951B-BBFEE7BC4229Q34774808-D2B741D4-AA35-4CC8-BF15-47E257F7821EQ35651275-63FE2A50-0CD6-45FA-889C-EC89C96F3F49Q35963673-FE481ADF-3306-4196-A7A7-07B0AC9F8AAEQ35987717-7AFCFE1E-EA08-4804-A49A-D2594FD36D9AQ36308346-AA20A0FC-AAF5-4D27-8DC4-61812C2F59F0Q38873050-7A56F817-8CCF-40EE-A03E-D6893FE6CA91Q41146226-926F7347-5FC2-4E55-B371-34478C3DD69DQ41925816-CC572DAF-F10D-4071-B72B-322313C0849DQ56892550-4C1E7FDD-4D9B-4B61-B2A5-5AF5268A1CC0Q56893922-4B11A05B-244F-41DF-8017-4D0A48AB38D6
P2860
Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Induction of hepatitis B virus ...... mentous phage display vaccine.
@ast
Induction of hepatitis B virus ...... mentous phage display vaccine.
@en
type
label
Induction of hepatitis B virus ...... mentous phage display vaccine.
@ast
Induction of hepatitis B virus ...... mentous phage display vaccine.
@en
prefLabel
Induction of hepatitis B virus ...... mentous phage display vaccine.
@ast
Induction of hepatitis B virus ...... mentous phage display vaccine.
@en
P2093
P1433
P1476
Induction of hepatitis B virus ...... mentous phage display vaccine.
@en
P2093
P304
P356
10.1016/S0264-410X(00)00561-2
P407
P577
2001-04-01T00:00:00Z